Please assess the completion status of the following clinical trial:

Trial Title: Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* All patients with an epidural catheter in situ for labor analgesia, status post a vaginal delivery, and scheduled for a postpartum tubal ligation under epidural anesthesia will be eligible~Exclusion Criteria:~* Allergy/hypersensitivity to morphine~* Allergy/hypersensitivity to ester-linked local anesthetics or para-amino benzoic acid (PABA)~* Body Mass Index \>40 kg/m2~* Patients using chronic opioids~* History of obstructive sleep apnea~* Any contraindication to epidural anesthesia

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- morphine - 2CP-saline (MCS) (Type: EXPERIMENTAL): morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision
- saline-2CP-morphine (SCM) (Type: EXPERIMENTAL): saline will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level;morphine will be administered at skin incision
- saline-lidocaine-morphine (SLM) (Type: ACTIVE_COMPARATOR): Saline will be administered 30 min prior to epidural anesthesia; lidocaine will be used to achieve a T4 level; morphine will be administered at skin incision

Based on this trial design, predict the completion outcome and termination type (if applicable).